Henry Schein Inc (NAS:HSIC)
$ 73.31 -0.13 (-0.18%) Market Cap: 9.39 Bil Enterprise Value: 11.96 Bil PE Ratio: 24.68 PB Ratio: 2.62 GF Score: 88/100

Henry Schein Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 08:40PM GMT
Release Date Price: $58.82 (-3.83%)
Nathan Allen Rich
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good afternoon, everyone. My name is Nathan Rich, and I cover the dental space here at Goldman. Thank you for joining this session with Henry Schein, a leading distributor of products, technology and services to dental and medical practitioners globally. I'm very pleased to be able to introduce Stanley Bergman, Chairman and CEO of Henry Schein for over 30 years now; as well as Steve Paladino, the company's long-time CFO. Steve, I believe you wanted to start with the disclosure statement, and then we'll pass it over to Stanley to share some prepared remarks. Thank you both so much for joining us this afternoon.

Steven Paladino
Henry Schein, Inc. - Executive VP, CFO & Executive Director

Okay. Thank you, Nathan. Yes, I'd just like to comment that this conversation may include certain comments that are forward-looking statements. And as people know, our -- there are risks and uncertainties in our business and those forward-looking statements may differ from actual results. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot